{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T22:59:40Z","timestamp":1765666780833},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11938-007-0069-0","type":"journal-article","created":{"date-parts":[[2008,3,15]],"date-time":"2008-03-15T10:46:26Z","timestamp":1205577986000},"page":"259-272","source":"Crossref","is-referenced-by-count":14,"title":["Functional dyspepsia: A new Rome III paradigm"],"prefix":"10.1007","volume":"10","author":[{"given":"Smita L.S.","family":"Halder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,16]]},"reference":[{"issue":"Suppl2","key":"69_CR1","first-page":"II37","volume":"45","author":"N.J. Talley","year":"1999","unstructured":"Talley NJ, Stanghellini V, Heading RC, et al.: Functional gastroduodenal disorders. Gut 1999, 45(Suppl 2):II37\u2013II42.","journal-title":"Gut"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(05)70362-9","volume":"25","author":"G.R. Locke 3rd","year":"1996","unstructured":"Locke GR 3rd: The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996, 25:1\u201319.","journal-title":"Gastroenterol Clin North Am"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2165\/00019053-199201050-00003","volume":"1","author":"O. Nyren","year":"1992","unstructured":"Nyren O, Lindberg G, Lindstrom E, et al.: Economic costs of functional dyspepsia. Pharmacoeconomics 1992, 1:312\u2013324.","journal-title":"Pharmacoeconomics"},{"issue":"Suppl4","key":"69_CR4","first-page":"iv10","volume":"50","author":"P. Moayyedi","year":"2002","unstructured":"Moayyedi P, Mason J: Clinical and economic consequences of dyspepsia in the community. Gut 2002, 50(Suppl 4):iv10\u2013iv12.","journal-title":"Gut"},{"key":"69_CR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1155\/2002\/567684","volume":"16","author":"D. Armstrong","year":"2002","unstructured":"Armstrong D, Kazim F, Gervais M, Pyzyk M: Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice. Can J Gastroenterol 2002, 16:439\u2013450.","journal-title":"Can J Gastroenterol"},{"key":"69_CR6","first-page":"3","volume":"231","author":"R.C. Heading","year":"1999","unstructured":"Heading RC: Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol Suppl 1999, 231:3\u20138.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"69_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.gastro.2005.10.019","volume":"130","author":"G. Karamanolis","year":"2006","unstructured":"Karamanolis G, Caenepeel P, Arts J, Tack J: Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006, 130:296\u2013303.","journal-title":"Gastroenterology"},{"key":"69_CR8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J. Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, et al.: Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466\u20131479.","journal-title":"Gastroenterology"},{"key":"69_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(05)00153-9","volume":"3","author":"M. Camilleri","year":"2005","unstructured":"Camilleri M, Dubois D, Coulie B, et al.: Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005, 3:543\u2013552.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"69_CR10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","volume":"110","author":"V. Stanghellini","year":"1996","unstructured":"Stanghellini V, Tosetti C, Paternic A, et al.: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 110:1036\u20131042.","journal-title":"Gastroenterology"},{"key":"69_CR11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bpg.2004.04.007","volume":"18","author":"K.J. Lee","year":"2004","unstructured":"Lee KJ, Kindt S, Tack J: Pathophysiology of functional dyspepsia. Best Pract Res Clin Gastroenterol 2004, 18:707\u2013716.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"69_CR12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","volume":"121","author":"J. Tack","year":"2001","unstructured":"Tack J, Caenepeel P, Fischler B, et al.: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001, 121:526\u2013535.","journal-title":"Gastroenterology"},{"key":"69_CR13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0016-5085(99)70171-X","volume":"116","author":"M. Samsom","year":"1999","unstructured":"Samsom M, Verhagen MA, van Berge Henegouwen GP, Smout AJ: Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999, 116:515\u2013520.","journal-title":"Gastroenterology"},{"key":"69_CR14","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/gast.2002.33663","volume":"122","author":"J. Tack","year":"2002","unstructured":"Tack J, Demedts I, Dehondt G, et al.: Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002, 122:1738\u20131747.","journal-title":"Gastroenterology"},{"key":"69_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.gastro.2005.04.012","volume":"129","author":"F. Mearin","year":"2005","unstructured":"Mearin F, Perez-Oliveras M, Perello A, et al.: Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005, 129:98\u2013104.","journal-title":"Gastroenterology"},{"key":"69_CR16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","volume":"126","author":"G. Holtmann","year":"2004","unstructured":"Holtmann G, Siffert W, Haag S, et al.: G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004, 126:971\u2013979.","journal-title":"Gastroenterology"},{"key":"69_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11938-005-0026-8","volume":"8","author":"S.L. Halder","year":"2005","unstructured":"Halder SL, Talley NJ: Treatment of functional dyspepsia. Curr Treat Options Gastroenterol 2005, 8:325\u2013336.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"Suppl1","key":"69_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2036.2002.0160s1058.x","volume":"16","author":"N.J. Talley","year":"2002","unstructured":"Talley NJ, Quan C: Review article: Helicobacter pylori and nonuclear dyspepsia. Aliment Pharmacol Ther 2002, 16(Suppl 1):58\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bpg.2006.11.001","volume":"21","author":"K. Wolle","year":"2007","unstructured":"Wolle K, Malfertheiner P: Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol 2007, 21:315\u2013324.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"69_CR20","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006, 2:CD002096.","DOI":"10.1002\/14651858.CD002096.pub4"},{"key":"69_CR21","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1053\/j.gastro.2005.03.004","volume":"128","author":"A.C. Ford","year":"2005","unstructured":"Ford AC, Qume M, Moayyedi P, et al.: Helicobacter pylori \u201ctest and treat\u201d or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 2005, 128:1838\u20131844.","journal-title":"Gastroenterology"},{"key":"69_CR22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","volume":"127","author":"P. Moayyedi","year":"2004","unstructured":"Moayyedi P, Delaney BC, Vakil N, et al.: The efficacy of proton pump inhibitors in nonucler dyspepsia: a systematic review and economic analysis. Gastroenterology 2004, 127:1329\u20131337.","journal-title":"Gastroenterology"},{"key":"69_CR23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","volume":"5","author":"W.H. Wang","year":"2007","unstructured":"Wang WH, Huang JQ, Zheng GF, et al.: Effects of protonpump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007, 5:178\u2013185.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"69_CR24","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, et al.: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006, 4:CD001960.","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"69_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00365528809093840","volume":"23","author":"R. Gotthard","year":"1988","unstructured":"Gotthard R, Bodemar G, Brodin U, et al.: Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988, 23:7\u201318.","journal-title":"Scand J Gastroenterol"},{"key":"69_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJM198602063140603","volume":"314","author":"O. Nyren","year":"1986","unstructured":"Nyren O, Adami HO, Bates S, et al.: Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986, 314:339\u2013343.","journal-title":"N Engl J Med"},{"key":"69_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2036.1992.tb00265.x","volume":"6","author":"M. Tatsuta","year":"1992","unstructured":"Tatsuta M, Iishi H, Nakaizumi A, et al.: Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1992, 6:221\u2013228.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/gut.28.3.300","volume":"28","author":"R. Corinaldesi","year":"1987","unstructured":"Corinaldesi R, Stanghellini V, Raiti C, et al.: Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut 1987, 28:300\u2013305.","journal-title":"Gut"},{"key":"69_CR29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2036.1995.tb00364.x","volume":"9","author":"J.E. Kellow","year":"1995","unstructured":"Kellow JE, Cowan H, Shuter B, et al.: Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995, 9:153\u2013160.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1572-0241.2005.40280.x","volume":"100","author":"S.J. Veldhuyzen van Zanten","year":"2005","unstructured":"Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, et al.: A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol 2005, 100:1477\u20131488.","journal-title":"Am J Gastroenterol"},{"key":"69_CR31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J. Tack","year":"2004","unstructured":"Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology 2004, 127:1239\u20131255.","journal-title":"Gastroenterology"},{"key":"69_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","volume":"108","author":"J.L. Jackson","year":"2000","unstructured":"Jackson JL, O\u2019Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108:65\u201372.","journal-title":"Am J Med"},{"key":"69_CR33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","volume":"17","author":"J. Tack","year":"2003","unstructured":"Tack J, Broekaert D, Coulie B, et al.: Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther 2003, 17:603\u2013608.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00634443","volume":"99","author":"D. Loldrup","year":"1989","unstructured":"Loldrup D, Langemark M, Hansen HJ, et al.: Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology (Berl) 1989, 99:1\u20137.","journal-title":"Psychopharmacology (Berl)"},{"key":"69_CR35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H. Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A, et al.: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 93:160\u2013165.","journal-title":"Am J Gastroenterol"},{"key":"69_CR36","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00535-005-1687-8","volume":"40","author":"M. Hojo","year":"2005","unstructured":"Hojo M, Miwa H, Yokoyama T, et al.: Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol 2005, 40:1036\u20131042.","journal-title":"J Gastroenterol"},{"key":"69_CR37","first-page":"42","volume":"11","author":"H.A. Tindle","year":"2005","unstructured":"Tindle HA, Davis RB, Phillips RS, et al.: Trends in use of complementary and alternative medicine by US adults: 1997\u20132002. Altern Ther Health Med 2005, 11:42\u201349.","journal-title":"Altern Ther Health Med"},{"key":"69_CR38","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1046\/j.1365-2036.2002.01339.x","volume":"16","author":"C. J. Thompson","year":"2002","unstructured":"Thompson Coon J, Ernst E: Herbal medicinal products for non-ulcer dyspepsia. Aliment Pharmacol Ther 2002, 16:1689\u20131699.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR39","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","volume":"20","author":"J. Melzer","year":"2004","unstructured":"Melzer J, Rosch W, Reichling J, et al.: Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 2004, 20:1279\u20131287.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2007.01142.x","volume":"102","author":"A.N. Pilichiewicz","year":"2007","unstructured":"Pilichiewicz AN, Horowitz M, Russo A, et al.: Effects of Iberogast((R)) on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol 2007, 102:1\u20138.","journal-title":"Am J Gastroenterol"},{"key":"69_CR41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1046\/j.1365-2036.2003.01767.x","volume":"18","author":"G. Holtmann","year":"2003","unstructured":"Holtmann G, Adam B, Haag S, et al.: Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther 2003, 18:1099\u20131105.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR42","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/gut.2004.062034","volume":"54","author":"G.H. Song","year":"2005","unstructured":"Song GH, Leng PH, Gwee KA, et al.: Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study. Gut 2005, 54:1402\u20131407.","journal-title":"Gut"},{"key":"69_CR43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MCG.0b013e318031457a","volume":"41","author":"G. Klupinska","year":"2007","unstructured":"Klupinska G, Poplawski T, Drzewoski J, et al.: Therapeutic effect of melatonin in patients with functional dyspepsia. J Clin Gastroenterol 2007, 41:270\u2013274.","journal-title":"J Clin Gastroenterol"},{"key":"69_CR44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-3999(94)90033-7","volume":"38","author":"T.T. Haug","year":"1994","unstructured":"Haug TT, Svebak S, Wilhelmsen I, et al.: Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res 1994, 38:281\u2013291.","journal-title":"J Psychosom Res"},{"key":"69_CR45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0016-5085(86)90864-4","volume":"90","author":"N.J. Talley","year":"1986","unstructured":"Talley NJ, Fung LH, Gilligan IJ, et al.: Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology 1986, 90:886\u2013892.","journal-title":"Gastroenterology"},{"key":"69_CR46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00006842-199405000-00001","volume":"56","author":"T.T. Haug","year":"1994","unstructured":"Haug TT, Svebak S, Hausken T, et al.: Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 1994, 56:181\u2013186.","journal-title":"Psychosom Med"},{"key":"69_CR47","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00004836-200403000-00007","volume":"38","author":"S.L. Lorena","year":"2004","unstructured":"Lorena SL, Tinois E, Brunetto SQ, et al.: Gastric emptying and intragastric distribution of a solid meal in functional dyspepsia: influence of gender and anxiety. J Clin Gastroenterol 2004, 38:230\u2013236.","journal-title":"J Clin Gastroenterol"},{"key":"69_CR48","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/BF01296514","volume":"31","author":"M. Camilleri","year":"1986","unstructured":"Camilleri M, Malagelada JR, Kao PC, et al.: Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci 1986, 31:1169\u20131177.","journal-title":"Dig Dis Sci"},{"key":"69_CR49","doi-asserted-by":"crossref","unstructured":"Soo S, Moayyedi P, Deeks J, et al.: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005, 2:CD002301.","DOI":"10.1002\/14651858.CD002301.pub4"},{"key":"69_CR50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0022-3999(94)90026-4","volume":"38","author":"T.T. Haug","year":"1994","unstructured":"Haug TT, Wilhelmsen I, Svebak S, et al.: Psychotherapy in functional dyspepsia. J Psychosom Res 1994, 38:735\u2013744.","journal-title":"J Psychosom Res"},{"key":"69_CR51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/gast.2000.16493","volume":"119","author":"J. Hamilton","year":"2000","unstructured":"Hamilton J, Guthrie E, Creed F, et al.: A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000, 119:661\u2013669.","journal-title":"Gastroenterology"},{"key":"69_CR52","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.37071","volume":"123","author":"E.L. Calvert","year":"2002","unstructured":"Calvert EL, Houghton LA, Cooper P, et al.: Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002, 123:1778\u20131785.","journal-title":"Gastroenterology"},{"key":"69_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/16506078809456271","volume":"17","author":"S. Bates","year":"1988","unstructured":"Bates S, Sjoden PO, Nyren O: Behavioral treatment of nonulcer dyspepsia. Scand J Behav Ther 1988, 17:155\u2013165.","journal-title":"Scand J Behav Ther"},{"key":"69_CR54","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/gut.31.8.896","volume":"31","author":"A. Prior","year":"1990","unstructured":"Prior A, Colgan SM, Whorwell PJ: Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut 1990, 31:896\u2013898.","journal-title":"Gut"},{"key":"69_CR55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2036.2007.03277.x","volume":"25","author":"S. Haag","year":"2007","unstructured":"Haag S, Senf W, Tagay S, et al.: Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther 2007, 25:973\u2013986.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"M.D. Gershon","year":"2007","unstructured":"Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007, 132:397\u2013414.","journal-title":"Gastroenterology"},{"key":"69_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000090309","volume":"24","author":"M. Tonini","year":"2006","unstructured":"Tonini M, Pace F: Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig Dis 2006, 24:59\u201369.","journal-title":"Dig Dis"},{"key":"69_CR58","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J. Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346\u20131352.","journal-title":"Gastroenterology"},{"key":"69_CR59","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gut.42.6.814","volume":"42","author":"H. Mertz","year":"1998","unstructured":"Mertz H, Fullerton S, Naliboff B, et al.: Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998, 42:814\u2013822.","journal-title":"Gut"},{"key":"69_CR60","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/gut.46.4.468","volume":"46","author":"J. Tack","year":"2000","unstructured":"Tack J, Coulie B, Wilmer A, et al.: Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000, 46:468\u2013473.","journal-title":"Gut"},{"key":"69_CR61","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2004.07.005","volume":"127","author":"J. Tack","year":"2004","unstructured":"Tack J, Caenepeel P, Corsetti M, et al.: Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004, 127:1058\u20131066.","journal-title":"Gastroenterology"},{"key":"69_CR62","doi-asserted-by":"crossref","first-page":"T2032","DOI":"10.1053\/j.gastro.2005.10.019","volume":"130","author":"G. Karamanolis","year":"2006","unstructured":"Karamanolis G, Kindt S, Vos R, et al.: Effect of tegaserod on meal-related symptoms induced by the nutrient drink test in man [abstract]. Gastroenterology 2006, 130:T2032.","journal-title":"Gastroenterology"},{"key":"69_CR63","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","volume":"13","author":"M. Camilleri","year":"1999","unstructured":"Camilleri M, Mayer EA, Drossman DA, et al.: Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999, 13:1149\u20131159.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","volume":"15","author":"N.J. Talley","year":"2001","unstructured":"Talley NJ, Van Zanten SV, Saez LR, et al.: A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther 2001, 15:525\u2013537.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2036.2000.00742.x","volume":"14","author":"C. Mansi","year":"2000","unstructured":"Mansi C, Borro P, Giacomini M, et al.: Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000, 14:561\u2013569.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2036.2002.01180.x","volume":"16","author":"E. Distrutti","year":"2002","unstructured":"Distrutti E, Fiorucci S, Hauer SK, et al.: Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. Aliment Pharmacol Ther 2002, 16:613\u2013622.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1542-3565(04)00059-X","volume":"2","author":"F. Mearin","year":"2004","unstructured":"Mearin F, Rodrigo L, Perez-Mota A, et al.: Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial. Clin Gastroenterol Hepatol 2004, 2:301\u2013308.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"69_CR68","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.102.048603","volume":"306","author":"T. Tsubouchi","year":"2003","unstructured":"Tsubouchi T, Saito T, Mizutani F, et al.: Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo. J Pharmacol Exp Ther 2003, 306:787\u2013793.","journal-title":"J Pharmacol Exp Ther"},{"key":"69_CR69","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"G. Holtmann","year":"2006","unstructured":"Holtmann G, Talley NJ, Liebregts T, et al.: A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006, 354:832\u2013840.","journal-title":"N Engl J Med"},{"key":"69_CR70","first-page":"641","volume":"132","author":"N.J. Talley","year":"2007","unstructured":"Talley NJ, Tack JF, Ptak T, et al.: Efficacy and safety of itopride in functional dyspepsia: results of two phase III multicentre, randomized, double-blind, placebo-controlled trials [abstract]. Gastroenterology 2007, 132:641.","journal-title":"Gastroenterology"},{"key":"69_CR71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2982.2006.00869.x","volume":"19","author":"R.S. Choung","year":"2007","unstructured":"Choung RS, Talley NJ, Peterson J, et al.: A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil 2007, 19:180\u2013187.","journal-title":"Neurogastroenterol Motil"},{"key":"69_CR72","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1572-0241.2006.00883.x","volume":"101","author":"M. Stefano Di","year":"2006","unstructured":"Di Stefano M, Vos R, Klersy C, et al.: Neostigmine-induced postprandial phasic contractility in the proximal stomach and dyspepsia-like symptoms in healthy volunteers. Am J Gastroenterol 2006, 101:2797\u20132804.","journal-title":"Am J Gastroenterol"},{"key":"69_CR73","doi-asserted-by":"crossref","first-page":"G988","DOI":"10.1152\/ajpgi.00419.2003","volume":"287","author":"G. Sarnelli","year":"2004","unstructured":"Sarnelli G, Sifrim D, Janssens J, Tack J: Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol 2004, 287:G988\u2013G992.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"69_CR74","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2004.07.005","volume":"127","author":"J. Tack","year":"2004","unstructured":"Tack J, Caenepeel P, Corsetti M, Janssens J: Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 2004, 127:1058\u20131066.","journal-title":"Gastroenterology"},{"key":"69_CR75","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.2000.278.5.R1217","volume":"278","author":"C. Feinle","year":"2000","unstructured":"Feinle C, Grundy D, Otto B, et al.: Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Comp Physiol 2000, 278:R1217\u2013R1223.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"69_CR76","doi-asserted-by":"crossref","first-page":"G183","DOI":"10.1152\/ajpgi.00434.2003","volume":"286","author":"T.H. Moran","year":"2004","unstructured":"Moran TH, Kinzig KP: Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 2004, 286:G183\u2013G188.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"69_CR77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.48.3.347","volume":"48","author":"C. Feinle","year":"2001","unstructured":"Feinle C, Meier O, Otto B, et al.: Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001, 48:347\u2013355.","journal-title":"Gut"},{"key":"69_CR78","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5085(99)70226-X","volume":"116","author":"M. Delvaux","year":"1999","unstructured":"Delvaux M, Louvel D, Lagier E, et al.: The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 1999, 116:38\u201345.","journal-title":"Gastroenterology"},{"key":"69_CR79","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.41.5.664","volume":"41","author":"N.W. Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:664\u2013668.","journal-title":"Gut"},{"key":"69_CR80","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/BF02087560","volume":"39","author":"B. Fraitag","year":"1994","unstructured":"Fraitag B, Homerin M, Hecketsweiler P: Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci 1994, 39:1072\u20131077.","journal-title":"Dig Dis Sci"},{"key":"69_CR81","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-2036.2003.01670.x","volume":"18","author":"S. Delgado-Aros","year":"2003","unstructured":"Delgado-Aros S, Chial HJ, Cremonini F, et al.: Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther 2003, 18:507\u2013514.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR82","first-page":"M1154","volume":"132","author":"R.S. Choung","year":"2007","unstructured":"Choung RS, Talley NJ, Chitkara DK, et al.: A randomized, double-blind, placebo-controlled trial to evaluate the effects of the kappa opioid agonist asimadoline versus placebo on global gastric function and dyspepsia score in patients with functional dyspepsia [abstract]. Gastroenterology 2007, 132:M1154.","journal-title":"Gastroenterology"},{"key":"69_CR83","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2982.2003.00420.x","volume":"15","author":"J. Fioramonti","year":"2003","unstructured":"Fioramonti J, Gaultier E, Toulouse M, et al.: Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action. Neurogastroenterol Motil 2003, 15:363\u2013369.","journal-title":"Neurogastroenterol Motil"},{"key":"69_CR84","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2036.2006.03078.x","volume":"24","author":"E.A. Mayer","year":"2006","unstructured":"Mayer EA, Tillisch K, Bradesi S: Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006, 24:919\u2013933.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR85","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","volume":"22","author":"M. Duncan","year":"2005","unstructured":"Duncan M, Davison JS, Sharkey KA: Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 2005, 22:667\u2013683.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR86","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1046\/j.1365-2036.2002.01280.x","volume":"16","author":"M. Bortolotti","year":"2002","unstructured":"Bortolotti M, Coccia G, Grossi G, Miglioli M: The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002, 16:1075\u20131082.","journal-title":"Aliment Pharmacol Ther"},{"key":"69_CR87","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2036.2006.03022.x","volume":"24","author":"J. Hammer","year":"2006","unstructured":"Hammer J: Effect of repeated capsaicin ingestion on intestinal chemosensation and mechanosensation. Aliment Pharmacol Ther 2006, 24:679\u2013686.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0069-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-007-0069-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0069-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:36Z","timestamp":1559422596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-007-0069-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s11938-007-0069-0","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}